Your Article Summary
See Latest ArticlesBreast cancer resistant protein (BCRP) is a molecular determinant of the outcome of photodynamic therapy (PDT) for centrally located early lung cancer
Lung Cancer, 07/02/09
Usuda J et al. - Photofrin may be a substrate of BCRP and be pumped out from the cells, therefore, BCRP may be a molecular determinant of the outcome of Photofrin-PDT.
Related Articles
Lung cancer: a biologically different disease in women?
Women's Health, 10/30/09
Relevance Score: 73%
Oestrogen plus progestin and lung cancer in postmenopausal women (Womens Health Initiative trial): a post-hoc analysis of a randomised controlled trial
The Lancet, 10/12/09
Relevance Score: 72%
Haplotype and Cell Proliferation Analyses of Candidate Lung Cancer Susceptibility Genes on Chromosome 15q24-25.1
Cancer Research, 10/06/09
Relevance Score: 71%
Noninvasive detection of lung cancer by analysis of exhaled breath
BMC Cancer, 10/09/09
Relevance Score: 70%
African American lung cancer patients may have different response to new cancer-fighting drugs
EurekAlert, 10/08/09
Relevance Score: 70%
Today in Photodermatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of LED Phototherapy of Three Distinct Wavelengths on Fibroblasts on Wound Healing
Photomedicine and Laser Surgery, 12/14/09
Poromas and porokeratosis in a patient treated for solid-organ and haematological malignancies
Clinical and Experimental Dermatology, 12/14/09
SPF-RR sequential photothermal fractional resurfacing and remodeling with the variable pulse Er:YAG laser and scanner-assisted Nd:YAG laser
Journal of Cosmetic and Laser Therapy, 12/11/09